[Serum levels of proinflammatory cytokines in women with uterine myomas].
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
This study measured serum levels of IL-1 alpha, IL-6, and TNF-alpha in women with uterine myomas, finding significantly elevated IL-1 alpha in patients compared to controls.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The levels of proinflammatory cytokines, namely IL-1 alpha, IL-6 and TNF-alpha were determined in blood serum of 26 women with uterine myomas and in 20 healthy controls. A significantly elevated concentration of IL-1 alpha was found in patients with uterine myomas. Levels of IL-6 and TNF-alpha were insignificantly higher in women with myomas. The obtained results indicate the possible role of IL-1 alpha in the pathogenesis of uterine myomas--further studies are needed to elucidate the role of proinflammatory cytokines in the proliferative disorders of myometrium.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis 2005
- Are uterine leiomyoma a consequence of a chronically inflammatory immune system? 2012
- Cyclooxygenase-2 Inhibitor, Celecoxib, Inhibits Leiomyoma Cell Proliferation Through the Nuclear Factor κB Pathway 2014
- CYTOKINE EXPRESSION PROFILES OF PERITONEAL FLUID IN THE PATIENTS WITH UTERINE LEIOMYOMA 2014
Cited by (4)
- CYTOKINE EXPRESSION PROFILES OF PERITONEAL FLUID IN THE PATIENTS WITH UTERINE LEIOMYOMA 2014
- Cyclooxygenase-2 Inhibitor, Celecoxib, Inhibits Leiomyoma Cell Proliferation Through the Nuclear Factor κB Pathway 2014
- Are uterine leiomyoma a consequence of a chronically inflammatory immune system? 2012
- Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis 2005
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK